VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

SABCS 2022 | Remaining questions regarding HER2-low breast cancer

Rani Bansal • 7 Dec 2022
SABCS 2022
Breast Cancer
Molecular Profiling

More from Rani Bansal

0:45
The evolution of HER2-low breast cancer from primary to recurrence
Rani Bansal • 7 Dec 2022
0:32
Highlights in HER2-low breast cancer at SABCS 2022
Rani Bansal • 7 Dec 2022
1:26
Genomic and transcriptomic landscape of HER2-low breast cancer
Rani Bansal • 7 Dec 2022

Related Videos

2:52
IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC
Peter Schmid
1:52
What impact will biosimilars have on clinical life?
Diana Lüftner
1:22
Drug shortages around the world: why communication is key
Fatima Cardoso
2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals